stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / JAZZ / Net Income

Jazz Pharmaceuticals plc Net Income 2009–2025

Jazz Pharmaceuticals plc (JAZZ) annual net income by fiscal year, computed from SEC filings.

Fiscal yearNet IncomeNet marginChange (YoY)
FY 2025$-356.15M-8.3%-163.6%
FY 2024$560.12M13.8%+35.0%
FY 2023$414.83M10.8%+285.1%
FY 2022$-224.06M-6.1%+32.0%
FY 2021$-329.67M-10.7%-238.2%
FY 2020$238.62M10.1%-54.4%
FY 2019$523.37M24.2%+17.1%
FY 2018$447.10M23.6%-8.4%
FY 2017$487.85M30.1%+22.9%
FY 2016$396.83M26.7%+20.4%
FY 2015$329.54M24.9%+464.4%
FY 2014$58.39M5.0%-73.0%
FY 2013$216.31M24.8%-25.0%
FY 2012$288.59M49.2%+130.9%
FY 2011$124.98M45.9%+281.3%
FY 2010$32.78M18.9%+579.5%
FY 2009$-6.84M-5.3%

Source: Jazz Pharmaceuticals plc SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Jazz Pharmaceuticals plc

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Jazz Pharmaceuticals plc — frequently asked questions

What is Jazz Pharmaceuticals plc's net income?

Jazz Pharmaceuticals plc (JAZZ) reported net income of $-356.15M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from Jazz Pharmaceuticals plc's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More JAZZ financial history

Full JAZZ fundamentals page → · All 1,500+ companies →